|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.900 EUR | 0.00% |
|
-1.04% | +33.37% |
| 06-29 | Sopharma AD Approves Gross Dividend for 2025 | CI |
| 06-22 | Sopharma AD Reports Sales Results for the Month and Year to Date Ended May 2026 | CI |
| Market Cap | 1.91B 1.15B 1B 926M 855M 1.62B 109B 1.65B 11.07B 4.35B 53.93B 4.31B 4.22B 185B | P/E 2024 |
12.3x | P/E 2025 | 7.16x |
|---|---|---|---|---|---|
| Enterprise Value | 2.45B 1.47B 1.29B 1.19B 1.1B 2.08B 140B 2.12B 14.2B 5.58B 69.2B 5.53B 5.41B 238B | EV / Sales 2024 |
0.66x | EV / Sales 2025 | 0.76x |
| Free-Float |
31.06% | Yield 2024 |
2.68% | Yield 2025 | - |
| 1 week | -1.04% | ||
| Current month | -1.55% | ||
| 1 month | +1.06% | ||
| 3 months | +8.57% | ||
| 6 months | +6.44% | ||
| Current year | +33.37% |
| 1 week | 1.85 |  | 1.94 |
| 1 month | 1.85 | | 1.94 |
| Current year | 1.41 | | 2 |
| 1 year | 1.21 | | 2 |
| 3 years | 0.89 | | 2 |
| 5 years | 0.58 | | 2 |
| 10 years | 0.41 | | 2 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ognian Donev
CEO | Chief Executive Officer | 42 | 01/10/2000 |
Boris Borisov
DFI | Director of Finance/CFO | - | 01/01/2002 |
Ivaylo Mechev
ADM | Chief Administrative Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Ognian Donev
CHM | Chairman | 42 | 19/05/2010 |
| Director/Board Member | 63 | 19/05/2010 | |
| Director/Board Member | 61 | 12/07/2011 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 30/09/20 | Buy | Chief Executive Officer | 12,000 | 0.0089% | ||
| 30/09/20 | Donev Investments Ad
| Buy | Company | 25,489 | 0.0189% | |
| 29/09/20 | Buy | Chief Executive Officer | 1,000 | 0.0007% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | -1.04% | +43.19% | +108.77% | 1.15B | |
| +2.19% | +3.32% | -12.44% | -27.01% | 15.2B | |
| +2.06% | +5.47% | -20.59% | -28.31% | 7.15B | |
| -2.75% | +0.77% | -22.15% | -9.08% | 5.9B | |
| -0.15% | +0.75% | -17.78% | -34.07% | 3.6B | |
| +0.60% | -5.66% | -36.88% | -12.40% | 3.23B | |
| -1.02% | -1.92% | -28.65% | -46.19% | 3.18B | |
| 0.00% | +3.52% | +3.95% | -36.24% | 2.96B | |
| -0.24% | -2.48% | +100.78% | - | 2.59B | |
| -2.03% | -0.29% | -21.45% | -3.72% | 2.45B | |
| Average | -0.13% | -0.04% | -1.20% | -9.80% | 4.74B | |
| Weighted average by Cap. | +0.51% | +1.45% | -9.94% | -21.59% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 2.14B 1.28B 1.12B 1.04B 958M 1.82B 123B 1.85B 12.39B 4.86B 60.37B 4.82B 4.72B 208B | 2.63B 1.58B 1.38B 1.28B 1.18B 2.24B 151B 2.27B 15.24B 5.99B 74.29B 5.94B 5.81B 255B |
| Net income | 77.85M 46.75M 40.9M 37.72M 34.84M 66.11M 4.46B 67.22M 451M 177M 2.2B 176M 172M 7.55B | 134M 80.19M 70.15M 64.7M 59.76M 113M 7.65B 115M 773M 304M 3.77B 301M 295M 12.95B |
| Net Debt | 444M 267M 233M 215M 199M 377M 25.44B 384M 2.57B 1.01B 12.53B 1B 980M 43.09B | 541M 325M 284M 262M 242M 460M 31B 467M 3.13B 1.23B 15.27B 1.22B 1.19B 52.51B |
Employees
6,005
Sector
Drug Retailers
Calendar
07-30 -
Earnings release - Q2 2026
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/07/26 | €1.900 | 0.00% | 439 |
| 09/07/26 | €1.900 | -1.55% | 2,430 |
| 08/07/26 | €1.930 | -0.26% | 6,672 |
| 07/07/26 | €1.935 | 0.00% | 887 |
| 06/07/26 | €1.935 | +0.78% | 3,812 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- SFA Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
